A hypermethylation of CYP3A4, ALB and FBP1 promoter regions, among others, occurs in HCC cells, and demethylating treatments result in significant promoter demethylation accompanied by the induction of their expression levels [25,26]. Here, FBP1 is linked to hepatocellular carcinoma.